In today’s recent session, 0.4 million shares of the SpringWorks Therapeutics Inc (NASDAQ:SWTX) have been traded, and its beta is 0.74. Most recently the company’s share price was $46.37, and it changed around -$0.84 or -1.79% from the last close, which brings the market valuation of the company to $3.47B. SWTX at last check was trading at a discount to its 52-week high of $62.00, offering almost -33.71% off that amount. The share price’s 52-week low was $28.21, which indicates that the recent value has risen by an impressive 39.16% since then. We note from SpringWorks Therapeutics Inc’s average daily trading volume that its 10-day average is 1.68 million shares, with the 3-month average coming to 2.41 million.
SpringWorks Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.12. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended SWTX as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. SpringWorks Therapeutics Inc is expected to report earnings per share of -0.74 for the current quarter.
SpringWorks Therapeutics Inc (NASDAQ:SWTX) trade information
Instantly SWTX has been showing red trend so far today with a performance of -1.79% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 51.43 on recent trading dayincreased the stock’s daily price by 9.84%. The company’s shares are currently up 28.33% year-to-date, but still down -8.42% over the last five days. On the other hand, SpringWorks Therapeutics Inc (NASDAQ:SWTX) is -14.19% down in the 30-day period. We can see from the shorts that 7.53 million shares have been sold at a short interest cover period of 2.74 day(s).
The consensus price target as assigned by Wall Street analysts is $78, which translates to bulls needing to increase their stock price by 40.55% from its current value. Analyst projections state that SWTX is forecast to be at a low of $78 and a high of $78.
SpringWorks Therapeutics Inc (SWTX) estimates and forecasts
The year-over-year growth rate is expected to be 82.39%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 66.93M in revenue for the current quarter. 4 analysts expect SpringWorks Therapeutics Inc to make 75.27M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 21.01M and 59.73M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 218.64%. Forecasts for the next quarter put sales growth at 26.01%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -24.25%.
SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.78% of SpringWorks Therapeutics Inc shares, and 115.86% of them are in the hands of institutional investors. The stock currently has a share float of 117.96%. SpringWorks Therapeutics Inc stock is held by 309.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 15.0638% of the shares, which is about 11.11 million shares worth $418.6 million.
VANGUARD GROUP INC, with 8.8715% or 6.54 million shares worth $246.53 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Growth Company Fund and SMALLCAP WORLD FUND INC were the top two Mutual Funds as of Jan 31, 2025. The former held 3.56 shares worth $164.67 million, making up 4.74% of all outstanding shares. On the other hand, SMALLCAP WORLD FUND INC held roughly 2.34 shares worth around $108.45 million, which represents about 3.12% of the total shares outstanding.
